Protein Profiles of Bronchoalveolar Lavage Fluid from Patients with Pulmonary Sarcoidosis
- 15 May 2006
- journal article
- research article
- Published by American Thoracic Society in American Journal of Respiratory and Critical Care Medicine
- Vol. 173 (10), 1145-1154
- https://doi.org/10.1164/rccm.200507-1126oc
Abstract
Pulmonary sarcoidosis is a multisystem granulomatous disease with various clinical phenotypes. So far, there has been little information on protein patterns (PPs) of bronchoalveolar lavage fluid (BALF) from patients with sarcoidosis and no data are available on PPs in clinical disease subtypes. To investigate the PP of BALF from patients with pulmonary sarcoidosis, to evaluate whether PPs reflect disease course as assessed by chest X-ray (CXR), and to compare PPs between patients with/without Löfgren's syndrome. Surface-enhanced laser desorption/ionization-time-of-flight mass spectroscopy was applied to investigate PPs in unconcentrated BALF from 65 patients (CXR stage I, n = 32; CXR stage II, n = 22, CXR stage III, n = 11) and 23 healthy control subjects. The Mann-Whitney U test was used to detect differentially expressed protein peaks. After reversed-phase fractionation, peptide fingerprint mapping and immunodepletion were used to identify deregulated (up-regulated or down-regulated) proteins. Forty differentially expressed protein entities (2.75-185.62 kD) were detected in patients with pulmonary sarcoidosis versus control subjects (p < 0.05). Whereas 13 peaks (33%) were present across all CXR stages, 27 (67%) were specific for particular CXR stages. Comparison of PPs between CXR stage I patients with or without Löfgren's syndrome revealed 25 differentially expressed peaks. The total number of deregulated peaks and also of those associated with sarcoidosis as a whole were markedly lower in patients with Löfgren's syndrome in comparison with other sarcoid phenotypes. Human serum albumin, alpha1-antitrypsin, and protocadherin-2 precursor were identified from sarcoidosis-associated PP. Surface-enhanced laser desorption/ionization-time-of-flight mass spectroscopy enables determination of protein patterns in sarcoid BALF and allows detection of protein patterns linked to a particular disease course.Keywords
This publication has 57 references indexed in Scilit:
- Detection and identification of heat shock protein 10 as a biomarker in colorectal cancer by protein profilingProteomics, 2006
- Valid data from large-scale proteomics studiesNature Methods, 2005
- Proteomic analysis of nipple aspirate fluid using SELDI‐TOF‐MSInternational Journal of Cancer, 2005
- Studies on protocadherin-2 expression in the human fetal central nervous systemCongenital Anomalies, 2004
- Inhibition of lipopolysaccharide-mediated human monocyte activation, in vitro, by α1-antitrypsinBiochemical and Biophysical Research Communications, 2004
- Proteomics: current techniques and potential applications to lung diseaseAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2004
- Biomarker Discovery and Identification in Laser Microdissected Head and Neck Squamous Cell Carcinoma with ProteinChip® Technology, Two-dimensional Gel Electrophoresis, Tandem Mass Spectrometry, and ImmunohistochemistryMolecular & Cellular Proteomics, 2003
- Expression of IFN-γ–inducible protein; monocyte chemotactic proteins 1, 3, and 4; and eotaxin in TH1- and TH2-mediated lung diseasesJournal of Allergy and Clinical Immunology, 2001
- Phylogenetic analysis of the cadherin superfamily allows identification of six major subfamilies besides several solitary members 1 1Edited by M. YanivJournal of Molecular Biology, 2000
- Clinical significance of MCP‐1 levels in BALF and serum in patients with interstitial lung diseasesEuropean Respiratory Journal, 1999